Jin Medical International (ZJYL) Operating Leases (2024 - 2025)
Jin Medical International's (ZJYL) quarterly Operating Leases came in at $30.1 billion in Q1 2025, down 83.25% year-over-year from $179.7 billion in Q1 2024, and down 68.71% quarter-over-quarter from $96.2 billion in Q3 2024.
Powered by 
Analysis
Jin Medical International (ZJYL) Operating Leases (2024 - 2025) Analysis & Trends
Jin Medical International has disclosed Operating Leases across 2 years of filings, most recently posting $30.1 billion for Q1 2025.
- In Q1 2025, Operating Leases fell 83.25% year-over-year to $30.1 billion; the TTM figure through Mar 2025 stood at $30.1 billion (down 83.25% YoY), while the FY2024 annual figure was $96.2 billion, changed N/A from the prior year.
- Operating Leases came in at $30.1 billion for Q1 2025 at Jin Medical International, down from $96.2 billion in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $179.7 billion in Q1 2024 to a low of $30.1 billion in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Jin Medical International | 16.67 Mn | -13.43 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 30.10 Bn |
| Sep 30, 2024 | 96.18 Bn |
| Mar 31, 2024 | 179.69 Bn |